Candel Therapeutics (CADL) EBIT Margin (2020 - 2022)
Candel Therapeutics' (CADL) quarterly EBIT Margin came in at 26132.26% in Q4 2022, up 10286774.0% year-on-year from N/an in Q4 2021, and up 8.78% quarter-over-quarter from 28648.39% in Q3 2022.
Candel Therapeutics (CADL) EBIT Margin (2020 - 2022) Analysis & Trends
Candel Therapeutics has disclosed EBIT Margin across 3 years of filings, most recently posting 26132.26% for Q4 2022.
- EBIT Margin for Q4 2022 came in at 26132.26%, up 10286774.0% year-over-year; the trailing twelve-month figure through Dec 2022 was 28000.81% (down 201394.0% YoY), and the FY2022 annual result was 27777.6%, down 205160.0% from the prior year.
- EBIT Margin came in at 26132.26% for Q4 2022 at Candel Therapeutics, up from 28648.39% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 8448.39% in Q2 2020 to a low of 129000.0% in Q4 2021.
- The 3-year median for EBIT Margin is 25900.0% (2021), against an average of 30554.55%.
- Across the five-year window, EBIT Margin sank 10924194 bps in 2021 and jumped 10286774 bps in 2022, its largest moves.
- Candel Therapeutics' EBIT Margin stood at 19758.06% in 2020, then sank by 553 bps to 129000.0% in 2021, then jumped by 80 bps to 26132.26% in 2022.
- The last three EBIT Margin figures came in at 26132.26% (Q4 2022), 28648.39% (Q3 2022), and 28235.48% (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Candel Therapeutics | 440.62 Mn | 440.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -26,132.26% |
| Sep 30, 2022 | -28,648.39% |
| Jun 30, 2022 | -28,235.48% |
| Mar 31, 2022 | -28,987.10% |
| Dec 31, 2021 | -129,000.00% |
| Sep 30, 2021 | -25,900.00% |
| Jun 30, 2021 | -17,100.00% |
| Mar 31, 2021 | -15,022.58% |
| Dec 31, 2020 | -19,758.06% |
| Sep 30, 2020 | -8,867.74% |
| Jun 30, 2020 | -8,448.39% |